Stereotaxis (STXS) EBIT Growth (3y) (2013 - 2026)
Stereotaxis (STXS) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 65.98% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 28.02% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -47.09% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 18.46% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -0.62% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -32.42% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -39.46% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06% |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | -2.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10% |
| Dec 31, 2025 | -8.23% |
| Sep 30, 2025 | -9.08% |
| Jun 30, 2025 | 8.43% |
| Mar 31, 2025 | -13.18% |
| Dec 31, 2024 | -31.57% |
| Sep 30, 2024 | -11.16% |
| Jun 30, 2024 | -21.09% |
| Mar 31, 2024 | -45.90% |
| Dec 31, 2023 | -65.19% |
| Sep 30, 2023 | -53.37% |
| Jun 30, 2023 | -40.03% |
| Mar 31, 2023 | -39.89% |
| Dec 31, 2022 | -55.43% |
| Sep 30, 2022 | -396.78% |
| Jun 30, 2022 | -52.53% |
| Mar 31, 2022 | -24.10% |
| Dec 31, 2021 | -78.72% |
| Sep 30, 2021 | -243.71% |
| Jun 30, 2021 | -75.62% |